• Proposed Re-evaluation Decision PRVD2022-08, Methyl Nonyl Ketone and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-04, Cymoxanil and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-08, Tebuconazole and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-01, Flufenacet and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2022-01, Trinexapac-ethyl and Its Associated End-use Products